Cytokinetics, Incorporated

CYTK · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$225$75$74$95
Short-Term Investments$737$783$865$981
Receivables$2$8$2$17
Inventory$0$0$0$0
Other Curr. Assets$13$20$16$15
Total Curr. Assets$977$887$956$1,108
Property Plant & Equip (Net)$154$146$145$141
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$289$178$151$145
Tax Assets$0$0$0$0
Other NC Assets$17$15$13$8
Total NC Assets$459$339$308$294
Other Assets$0$0$0$0
Total Assets$1,437$1,226$1,264$1,402
Liabilities
Payables$22$16$14$20
Short-Term Debt$38$34$33$30
Tax Payable$0$0$0$0
Deferred Revenue$2$1$52$52
Other Curr. Liab.$81$80$61$76
Total Curr. Liab.$142$131$160$180
LT Debt$1,159$824$759$758
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$657$639$612$599
Total NC Liab.$1,816$1,463$1,371$1,357
Other Liabilities$0$0$0$0
Cap. Leases$111$131$133$132
Total Liabilities$1,958$1,594$1,530$1,537
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$3,304-$2,998-$2,863-$2,702
AOCI$0-$0$2$2
Other Equity$2,782$2,629$2,595$2,564
Total Equity-$521-$369-$266-$135
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,437$1,226$1,264$1,402
Net Debt$971$783$717$694